GASTROINTESTINAL STROMAL TUMOUR

This adverse event was reported 2659 times

These drugs are most commonly taken by patients reporting GASTROINTESTINAL STROMAL TUMOUR:

# Drug Count
0 IMATINIB MESYLATE 478
1 SUNITINIB MALATE 438
2 REGORAFENIB 144
3 OMEPRAZOLE MAGNESIUM 89
4 FUROSEMIDE 66
5 NILOTINIB 66
6 OMEPRAZOLE 66
7 AMLODIPINE 62
8 ASPIRIN 59
9 RANITIDINE 59
See all common drugs associated with GASTROINTESTINAL STROMAL TUMOUR

GASTROINTESTINAL STROMAL TUMOUR is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ADENINE 1 0.0204
1 IMATINIB MESYLATE 478 0.0172
2 REGORAFENIB 144 0.0124
3 SUNITINIB MALATE 438 0.0112
4 METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE 1 0.0047
5 RIPRETINIB 23 0.0044
6 DEMECLOCYCLINE 1 0.0044
7 ADALIMUMAB-ADBM 1 0.0037
8 BERBERIS VULGARIS, ISATIS TINCTORIA, MORINDA CITRIFOLIA, PETIVERIA TETRANDRA, SCHINUS MOLLE, THYMOLUM, UVA-URSI 1 0.0034
9 SORBITOL 2 0.0033
See all drugs enriched for association with GASTROINTESTINAL STROMAL TUMOUR